CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Pore-forming toxins are critical virulence factors for many bacterial pathogens and are central to Staphylococcus aureus-mediated killing of host cells. S. aureus encodes pore-forming bi-component leukotoxins that are toxic towards neutrophils, but also specifically target other immune cells. Despite decades since the first description of staphylococcal leukocidal activity, the host factors responsible for the selectivity of leukotoxins towards different immune cells remain unknown. Here we identify the human immunodeficiency virus (HIV) co-receptor CCR5 as a cellular determinant required for cytotoxic targeting of subsets of myeloid cells and T lymphocytes by the S. aureus leukotoxin ED (LukED). We further demonstrate that LukED-dependent cell killing is blocked by CCR5 receptor antagonists, including the HIV drug maraviroc. Remarkably, CCR5-deficient mice are largely resistant to lethal S. aureus infection, highlighting the importance of CCR5 targeting in S. aureus pathogenesis. Thus, depletion of CCR5(+) leukocytes by LukED suggests a new immune evasion mechanism of S. aureus that can be therapeutically targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The respective immune cell receptor counterparts of these leukocidins have been identified (Alonzo et al., 2013; DuMont et al., 2013; Reyes-Robles et al., 2013; Spaan et al., 2013a; Spaan et al., 2014).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Alonzo et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
Self-citationLiu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Self-citationSamson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658
Lin, L., Ibrahim, A. S., Xu, X., Farber, J. M., Avanesian, V., Baquir, B., Fu, Y., French, S. W., Edwards, J. E., & Spellberg, B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000703 · Cited by 465
Research works printed but not linked: 1
- Van de Velde, H. Etude sur le mécanisme de la virulence du staphylocoque pyogène. Cellule 10, 403–460 (1894)
Cited by
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
“The S subunit recognizes a membrane protein receptor [a chemokine receptor for PVL and LukED [150,151] and an integrin for LukAB/GH [152]] and then recruits the F subunit, leading first to dimerization and ultimately, after considerable structural changes that facilitate membrane insertion, to the formation of an octa…”
BackgroundA guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Pore-forming toxins: ancient, but never really out of fashion
Peraro, M. D., & van der Goot, F. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.3 · Cited by 788
Otto, M. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.11.004 · Cited by 643
“Initially often believed to function in a receptor-independent fashion, the discovery of the LukDE receptor (CCR5) [12 ], and the subsequent discoveries of the PVL and LukGH (LukAB) receptors (C5aR, C5L2 and CD11b, respectively) [13,14 ], clearly showed that these toxins require receptor interaction for cytolytic acti…”
BackgroundStaphylococcal manipulation of host immune responses
Thammavongsa, V., Kim, H. K., Missiakas, D., & Schneewind, O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3521 · Cited by 598
Neutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
Quorum-sensing regulation in staphylococci—an overview
Le, K. Y., & Otto, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01174 · Cited by 490
“LukED causes lysis of phagocytic cells by targeting the CCR5 chemokine receptor on lymphocytes, macrophages and dendritic cells (Alonzo et al., 2013).”
BackgroundStaphylococcus aureus Secreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0039-2018 · Cited by 452
Self-citationPatching, S. G. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.04.028 · Cited by 458
“In recent work that demonstrated CCR5 to be a receptor for Staphylococcus aureus leukotoxin ED [58], SPR was used to show a direct interaction between the LukE subunit and CCR5 in whichbindingwas time-dependent and saturablewith an apparent dissociation constant (KD) of 39.”
BackgroundStaphylococcus aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments
Ahmad-Mansour, N., Loubet, P., Pouget, C., Dunyach-Remy, C., Sotto, A., Lavigne, J.-P., & Molle, V. (2021) · Toxins · doi:10.3390/toxins13100677 · Cited by 386
Role of Pore-Forming Toxins in Bacterial Infectious Diseases
Los, F. C. O., Randis, T. M., Aroian, R. V., & Ratner, A. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00052-12 · Cited by 402
CCL5/CCR5 axis in human diseases and related treatments
Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.004 · Cited by 378
“Other infections Besides, Toxoplasma gondii and Staphylococcus aureus are able to kill cells without triggering host immune response by taking advantage of CCL5/CCR5 axis.(88) Conversely, CCR5 in West Nile virus (WNV) infection plays an antiviral role.”
Phenol-soluble modulins – critical determinants of staphylococcal virulence
Cheung, G. Y. C., Joo, H.-S., Chatterjee, S. S., & Otto, M. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12057 · Cited by 369
Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors
Spaan, A. N., van Strijp, J. A. G., & Torres, V. J. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.27 · Cited by 347
Self-citationRelease of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform
Wang, X., Thompson, C. D., Weidenmaier, C., & Lee, J. C. (2018) · Nature Communications · doi:10.1038/s41467-018-03847-z · Cited by 326
Control of Phagocytosis by Microbial Pathogens
Uribe-Querol, E., & Rosales, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01368 · Cited by 306
“Although there are different leukocidins, they all are dimer proteins (e.g., LukAB, LukED, HlgAB, HlgCB, and LukSF-PV) that induce membrane permeability by the formation of octameric β-barrel pores on the cell membrane (120, 122, 123).”
BackgroundTargeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy
Kong, C., Neoh, H.-M., & Nathan, S. (2016) · Toxins · doi:10.3390/toxins8030072 · Cited by 317
“In animal models, LukS-PV and LukF-PV bind to TLR2 and TLR4 [21,22] whilst, in humans, the receptor for LukED is CCR5, whereas the receptors for PVL and LukAG/GH are C5aR, C5L2, and CD11b, respectively [23–25].”
BackgroundNeutrophils Versus Staphylococcus aureus: A Biological Tug of War
Spaan, A. N., Surewaard, B. G. J., Nijland, R., & van Strijp, J. A. G. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155746 · Cited by 307
The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors
Spaan, A. N., Henry, T., van Rooijen, W. J. M., Perret, M., Badiou, C., Aerts, P. C., Kemmink, J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.04.006 · Cited by 301
The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus
Alonzo, F., & Torres, V. J. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00055-13 · Cited by 276
“LukED and PVL both recognize GPCRs that are important for immune cell activation and chemotaxis (199, 227, 230).”
BackgroundMethodInfluentialSelf-citationBrown, A. F., Leech, J. M., Rogers, T. R., & McLoughlin, R. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00507 · Cited by 246
“LukED results in lower levels of pro-inflammatory cytokines and markedly reduced mortality in systemic infection models (229).”
BackgroundWuhan to World: The COVID-19 Pandemic
Kumar, A., Singh, R., Kaur, J., Pandey, S., Sharma, V., Thakur, L., Sati, S., Mani, S., Asthana, S., Sharma, T. K., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.596201 · Cited by 230
“Later, other pathogens (like Dengue or Staphylococcus aureus) were also observed to use the CCR5 signaling pathway for their entry or as a virulence factor (Alonzo et al., 2013).”
BackgroundStaphylococcus aureus toxins – Their functions and genetics
Grumann, D., Nübel, U., & Bröker, B. M. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.03.013 · Cited by 236
Neutrophils and Immunity: From Bactericidal Action to Being Conquered
Teng, T.-S., Ji, A.-L., Ji, X.-Y., & Li, Y.-Z. (2017) · Journal of Immunology Research · doi:10.1155/2017/9671604 · Cited by 232
Decoy exosomes provide protection against bacterial toxins
Keller, M. D., Ching, K. L., Liang, F.-X., Dhabaria, A., Tam, K., Ueberheide, B. M., Unutmaz, D., Torres, V. J., & Cadwell, K. (2020) · Nature · doi:10.1038/s41586-020-2066-6 · Cited by 238
Self-citationMiller, L. S., Fowler, V. G., Shukla, S. K., Rose, W. E., & Proctor, R. A. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz030 · Cited by 240
“PVL and HlgCB utilize C5aR1 and C5aR2 (Spaan et al. 2013a), LukED uses CCR5, CXCR1, and CXCR2 (Alonzo et al. 2013; Reyes-Robles et al. 2013), HlgAB and LukED share CXCR1 and CXCR2 as receptors but can also utilize CCR2 (Spaan et al. 2014), whereas LukAB binds to CD11b (DuMont et al. 2013).”
BackgroundRecent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Jiao, X., Nawab, O., Patel, T., Kossenkov, A. V., Halama, N., Jaeger, D., & Pestell, R. G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1167 · Cited by 232
“6, 7), poxvirus (8), and the Staphylococcus aureus poreforming leukotoxin ED (9).”
BackgroundTh1/Th2 Cell Differentiation and Molecular Signals
Zhang, Y., Zhang, Y., Gu, W., & Sun, B. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-9487-9_2 · Cited by 223
“They found that LukED was cytotoxic to a human T-cell line ectopically expressing CCR5 (HUT-R5); whereas another T-cell line (Jurkat), which lacks detectable CCR5, was insensitive [7].”
BackgroundMetal limitation and toxicity at the interface between host and pathogen
Becker, K. W., & Skaar, E. P. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12087 · Cited by 221
“LukED is a pore forming toxin which binds to leukocytes via CCR5 (Alonzo et al. 2013).”
BackgroundFlannagan, R. S., Heit, B., & Heinrichs, D. E. (2016) · Cellular Microbiology · doi:10.1111/cmi.12527 · Cited by 217
Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity
Seilie, E. S., & Bubeck Wardenburg, J. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.04.003 · Cited by 207
DuMont, A. L., Yoong, P., Day, C. J., Alonzo, F., McDonald, W. H., Jennings, M. P., & Torres, V. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305121110 · Cited by 216
“We observed that murine peritoneal exudate cells (PECs), which are highly susceptible to LukED, are resistant to LukAB (Fig.”
BackgroundSelf-citationImmune Evasion by Staphylococcus aureus
de Jong, N. W. M., van Kessel, K. P. M., & van Strijp, J. A. G. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0061-2019 · Cited by 194
“For example, a CCR5 antagonist often used in HIV treatment, maraviroc, also protects T-cells and myeloid cells from LukED-mediated toxicity (221).”
BackgroundAntimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus
Flannagan, R., Heit, B., & Heinrichs, D. (2015) · Pathogens · doi:10.3390/pathogens4040826 · Cited by 193
“aureus as soluble monomers and assemble into heterodimers at the surface of target cells [158,164,165].”
BackgroundSurewaard, B. G. J., de Haas, C. J. C., Vervoort, F., Rigby, K. M., DeLeo, F. R., Otto, M., van Strijp, J. A. G., & Nijland, R. (2013) · Cellular Microbiology · doi:10.1111/cmi.12130 · Cited by 189
“However, there has been controversy about the extent to which this toxin contributes to S. aureus pathogenesis (Bubeck Wardenburg et al., 2008; Kobayashi et al., 2011).”
BackgroundMolecular Determinants in Phagocyte-Bacteria Interactions
Kaufmann, S. H. E., & Dorhoi, A. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.014 · Cited by 186
Blake, K. J., Baral, P., Voisin, T., Lubkin, A., Pinho-Ribeiro, F. A., Adams, K. L., Roberson, D. P., Ma, Y. C., Otto, M., Woolf, C. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02448-6 · Cited by 184
Self-citationMouse models for infectious diseases caused by Staphylococcus aureus
Kim, H. K., Missiakas, D., & Schneewind, O. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.04.007 · Cited by 186
Reyes-Robles, T., Alonzo, F., Kozhaya, L., Lacy, D. B., Unutmaz, D., & Torres, V. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.005 · Cited by 179
Self-citationSpaan, A. N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E. A., Benito, Y., de Haas, C. J. C., Day, C. J., Jennings, M. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6438 · Cited by 166
Self-citationα-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis
Surewaard, B. G. J., Thanabalasuriar, A., Zeng, Z., Tkaczyk, C., Cohen, T. S., Bardoel, B. W., Jorch, S. K., Deppermann, C., Bubeck Wardenburg, J., Davis, R. P., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.017 · Cited by 146
Shettigar, K., & Murali, T. S. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03984-8 · Cited by 145
Rouha, H., Badarau, A., Visram, Z. C., Battles, M. B., Prinz, B., Magyarics, Z., Nagy, G., Mirkina, I., Stulik, L., Zerbs, M., et al. (2015) · mAbs · doi:10.4161/19420862.2014.985132 · Cited by 143
Staphylococcus aureus Elaborates Leukocidin AB To Mediate Escape from within Human Neutrophils
DuMont, A. L., Yoong, P., Surewaard, B. G. J., Benson, M. A., Nijland, R., van Strijp, J. A. G., & Torres, V. J. (2013) · Infection and Immunity · doi:10.1128/iai.00095-13 · Cited by 138
Self-citationThe T Cell Response to Staphylococcus aureus
Bröker, B., Mrochen, D., & Péton, V. (2016) · Pathogens · doi:10.3390/pathogens5010031 · Cited by 134
“Leukocidin LukDE is a two component toxin which lyses its targets after binding to the chemokine receptor CCR5, which is present on human T cells as well as on myeloid cells [140].”
BackgroundEntry inhibitors and their use in the treatment of HIV-1 infection
Haqqani, A. A., & Tilton, J. C. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.017 · Cited by 162
Involvement of Bacteria Other Than Clostridium difficile in Antibiotic-Associated Diarrhoea
Larcombe, S., Hutton, M. L., & Lyras, D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.02.001 · Cited by 143
Bacterial Toxins as Pathogen Weapons Against Phagocytes
do Vale, A., Cabanes, D., & Sousa, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00042 · Cited by 138
The Fall of a Dogma? Unexpected High T-Cell Memory Response to Staphylococcus aureus in Humans
Kolata, J. B., Kühbandner, I., Link, C., Normann, N., Vu, C. H., Steil, L., Weidenmaier, C., & Bröker, B. M. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv128 · Cited by 119
“In addition, the bacterial pore-forming α-toxin and Luk D/E kill human T-cells in culture [27, 29].”
BackgroundCell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids
DuMont, A. L., & Torres, V. J. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2013.10.004 · Cited by 111
Self-citationMolecular Characteristics and Pathogenicity of Staphylococcus aureus Exotoxins
Zhu, Z., Zuo, H., Li, S., Fang, R., Ono, H. K., & Hu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010395 · Cited by 133
Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
Self-citationImproved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves
Otto, M. J., & Chatterjee (2013) · Clinical Epidemiology · doi:10.2147/clep.s37071 · Cited by 136
“Clinical strains of S. aureus may produce four different types of bicomponent leukotoxins, namely PVL, γ -hemolysin, leukotoxin ED, and/or leukotoxin AB/GH. 181 Apart from γ -hemolysin, they are all MGE-encoded.”
The Expanding Therapeutic Perspective of CCR5 Blockade
Vangelista, L., & Vento, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01981 · Cited by 107
“LukE binds to human (and mouse) CCR5 on T cells, macrophages, and dendritic cells (35); subsequently, a bicomponent octamer formed by alternate LukE and LukD monomers assembles on the surface of target cells.”
BackgroundInfluentialWu, X., Xu, S., Zhao, P., Zhang, X., Yao, X., Sun, Y., Fang, R., & Ye, J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007897 · Cited by 112
T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion
Shepherd, F. R., & McLaren, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176144 · Cited by 112
“aureus α-toxin forms heptameric pores that destroy T cells [244], whilst leukocidin DE binds to CCR5 to kill T cells [245].”
BackgroundNon-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine
Tsai, C., Caldera, J. R., Hajam, I. A., Chiang, A. W. T., Tsai, C.-H., Li, H., Lázaro-Díez, M., Gonzalez, C., Trieu, D., Martins, G. A., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.06.006 · Cited by 107
CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis
Brelot, A., & Chakrabarti, L. A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.027 · Cited by 97
Staphylococcal Biofilms and Immune Polarization During Prosthetic Joint Infection
Gries, C. M., & Kielian, T. (2017) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-16-00636 · Cited by 90
Spaan, A. N., Schiepers, A., de Haas, C. J. C., van Hooijdonk, D. D. J. J., Badiou, C., Contamin, H., Vandenesch, F., Lina, G., Gerard, N. P., Gerard, C. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500604 · Cited by 93
Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics
Helaine, S., Conlon, B. P., Davis, K. M., & Russell, D. G. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.04.019 · Cited by 87
Paharik, A. E., Salgado‐Pabón, W., Meyerholz, D. K., White, M. J., Schlievert, P. M., & Horswill, A. R. (2016) · mSphere · doi:10.1128/msphere.00208-16 · Cited by 89
Perspectives on Treatment for Nonalcoholic Steatohepatitis
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.004 · Cited by 94
Vrieling, M., Boerhout, E. M., van Wigcheren, G. F., Koymans, K. J., Mols-Vorstermans, T. G. T., de Haas, C. J. C., Aerts, P. C., Daemen, I., van Kessel, K. P. M., Koets, A. P., et al. (2016) · Scientific Reports · doi:10.1038/srep37759 · Cited by 103
Sil, P., Hayes, C., Reaves, B. J., Breen, P., Quinn, S. P., Sokolove, J. B., & Rada, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600766 · Cited by 91
Tromp, A. T., van Gent, M., Abrial, P., Martin, A., Jansen, J. P., de Haas, C. J. C., van Kessel, K. P. M., Bardoel, B. W., Kruse, E. M., Bourdonnay, E., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0159-x · Cited by 84
Characterization of a Mouse-Adapted Staphylococcus aureus Strain
Holtfreter, S., Radcliff, F. J., Grumann, D., Read, H. M., Johnson, S., Monecke, S., Ritchie, S. R., Clow, F., Goerke, C., Bröker, B. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071142 · Cited by 84
Vrieling, M., Koymans, K. J., Heesterbeek, D. A. C., Aerts, P. C., Rutten, V. P. M. G., de Haas, C. J. C., van Kessel, K. P. M., Koets, A. P., Nijland, R., & van Strijp, J. A. G. (2015) · mBio · doi:10.1128/mbio.00335-15 · Cited by 91
“As a consequence, the range of susceptible cells is extended to subsets of T cells, inflam-matory macrophages, and dendritic cells (9, 10).”
InfluentialA genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis
Patel, H., & Rawat, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1204428 · Cited by 81
Suppression of Staphylococcus aureus virulence by a small-molecule compound
Gao, P., Ho, P., Yan, B., Sze, K. H., DAVIES, J. E., & Kao, R. Y. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720520115 · Cited by 80
“Several antivirulence attempts have focused on accessory gene regulator (agr) (9), the sortase enzyme system (10), the carotenoid biosynthetic pathway (CrtM and CrtN) (11, 12), and other regulatory pathways (MgrA and SarA) (13) or have directly targeted toxin proteins (14) and the toxins’ receptors (15).”
BackgroundOkumura, C. Y. M., & Nizet, V. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155711 · Cited by 76
Structural Insights into the Cytotoxic Mechanism of Vibrio parahaemolyticus PirAvp and PirBvp Toxins
Lin, S.-J., Hsu, K., & Wang, H. (2017) · Marine Drugs · doi:10.3390/md15120373 · Cited by 83
“Similarly, with other pore-forming toxins, receptors that bind these toxins, such as CCR5 and ADAM10, can also be considered in a reverse strategy for drug design [53,54].”
BackgroundZhang, X., Marichannegowda, M. H., Rakesh, K. P., & Qin, H.-L. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.05.002 · Cited by 73
Tissue-Specific Patterning of Host Innate Immune Responses by Staphylococcus aureus α-Toxin
Becker, R. E. N., Berube, B. J., Sampedro, G. R., DeDent, A. C., & Wardenburg, J. B. (2014) · Journal of Innate Immunity · doi:10.1159/000360006 · Cited by 76
Dumont, A., Yoong, P., Liu, X., Day, C. J., Chumbler, N. M., James, D. B. A., Alonzo, F., Bode, N. J., Lacy, D. B., Jennings, M. P., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01444-13 · Cited by 83
“CCR5 (13) and CXCR1 and CXCR2 (14) were recently described as specific cellular receptors for LukED, while the C5a receptors (17) and CD11b (18) were identified as receptors for PVL and LukAB, respectively.”
BackgroundSelf-citationIdentification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus
Koop, G., Vrieling, M., Storisteanu, D. M. L., Lok, L. S. C., Monie, T. P., van Wigcheren, G. F., Raisen, C. L., Ba, X., Gleadall, N., Hadjirin, N. F., et al. (2017) · Scientific Reports · doi:10.1038/srep40660 · Cited by 73
“Based on the high degree of similarity (91% amino-acid identity) between receptor binding components LukE and LukP, we hypothesized that the most likely receptors for LukPQ would comprise CXCR1, CXCR2, CCR5, and the Duffy antigen receptor (DARC) analogous to LukED 10,11 .”
Bröker, B. M., Holtfreter, S., & Bekeredjian‐Ding, I. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.11.008 · Cited by 80
Cole, J., Aberdein, J., Jubrail, J., & Dockrell, D. H. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.004 · Cited by 81
Selective biosensing of Staphylococcus aureus using chitosan quantum dots
Abdelhamid, H. N., & Wu, H. (2017) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2017.06.047 · Cited by 73
Innate Immune Signaling Activated by MDR Bacteria in the Airway
Parker, D., Ahn, D. S., Cohen, T. S., & Prince, A. S. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2015 · Cited by 75
Diep, B. A., Le, V. T. M., Visram, Z., Rouha, H., Stulik, L., Dip, E. C., Nagy, G., & Nagy, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01213-16 · Cited by 68
“LukED, which also recognizes CXCR1 and CXCR2 (and, in addition, CCR5 on lymphocytes), was shown to contribute to pathogenesis in murine bacteremia models (12, 13),”
BackgroundInfective Endocarditis in High-Income Countries
Nappi, F., Martuscelli, G., Bellomo, F., Singh, S. S. A., & Moon, M. R. (2022) · Metabolites · doi:10.3390/metabo12080682 · Cited by 71
Balasubramanian, D., Ohneck, E. A., Chapman, J., Weiss, A., Kim, M. K., Reyes-Robles, T., Zhong, J., Shaw, L. N., Lun, D. S., Ueberheide, B., et al. (2016) · mBio · doi:10.1128/mbio.00818-16 · Cited by 68
“To understand the role of RpiRc in the virulence of non-USA300 strains, we created rpiRc mutant and complemented isogenic versions of S. aureus Newman, a strain that has been widely used to study the role of LukED in murine bacteremia models (6, 7, 9).”
Self-citationShaghayegh, G., Cooksley, C. M., Ramezanpour, M., Wormald, P., Psaltis, A. J., & Vreugde, S. (2022) · Biomedicines · doi:10.3390/biomedicines10061362 · Cited by 72
Bella, S. D., Marini, B., Stroffolini, G., Geremia, N., Giacobbe, D. R., Campanile, F., Bartoletti, M., Alloisio, G., Risio, L. D., Viglietti, G., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05148-y · Cited by 72
“LukED specifically binds to chemokine receptors, with CCR5 being the first to be identified [ 46].”
Staphylococcal Immune Evasion Proteins: Structure, Function, and Host Adaptation
Koymans, K. J., Vrieling, M., Gorham, R. D., & van Strijp, J. A. G. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5017 · Cited by 66
Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract
Pivard, M., Moreau, K., & Vandenesch, F. (2021) · mSphere · doi:10.1128/msphere.00059-21 · Cited by 69
“Five leucocidins, namely, LukAB (LukGH) (117), LukDE (118), HlgAB, HlgCB, and PVL (119, 120), target macrophages after their interactions with their receptors, namely, CD11b for LukAB, CCR5, and CXCR1/2 receptors for LukDE (118, 121), CCR2 and CXCR1/2 for HlgAB, C5aR1/R2 for HlgCB, and C5aR1/R2 and CD45 for the PVL (1…”
BackgroundInfluentialStructural Basis of the Pore-Forming Toxin/Membrane Interaction
Li, Y., Li, Y., Mengist, H. M., Shi, C., Zhang, C., Wang, B., Li, T., Huang, Y., Xu, Y., & Jin, T. (2021) · Toxins · doi:10.3390/toxins13020128 · Cited by 65
Badarau, A., Rouha, H., Malafa, S., Logan, D. T., Håkansson, M., Stulik, L., Doležílková, I., Teubenbacher, A., Gross, K., Maierhofer, B., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598110 · Cited by 64
One-dimensional nanostructures based bio-detection
Chartuprayoon, N., Zhang, M., Bosze, W., Choa, Y., & Myung, N. V. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.07.043 · Cited by 59
Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis
Robles, T. R., Lubkin, A., Alonzo, F., Lacy, D. B., & Torres, V. J. (2016) · EMBO Reports · doi:10.15252/embr.201540994 · Cited by 63
Self-citationSeifert, L. L., Si, C., Saha, D., Sadic, M., de Vries, M., Ballentine, S., Briley, A., Wang, G., Valero-Jimenez, A. M., Mohamed, A., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007634 · Cited by 67
“PBMC were isolated from blood using a Ficoll-Paque PLUS (GE Amersham) gradient [66] and maintained in RPMI (Invitrogen).”
MethodJasinska, A. J., Pandrea, I., & Apetrei, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835994 · Cited by 64
“org 6 On the other hand, CCR5 is implicated in infections with CCR5-tropic pathogens, such as Dengue virus (123) and Staphylococcus aureus (124).”
BackgroundEmerging enterococcus pore-forming toxins with MHC/HLA-I as receptors
Xiong, X., Tian, S., Yang, P., Lebreton, F., Bao, H., Sheng, K., Yin, L., Chen, P., Zhang, J., Qi, W., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.002 · Cited by 57
“…host protein receptors have been identified, establishing the key role of receptors in determining toxin host species and cell type selectivity (Alonzo et al., 2013; Bruggisser et al., 2020; DuMont et al., 2013; Reyes-Robles et al., 2013; Spaan et al., 2013, 2017; Tromp et al., 2018; Wilke and…”
BackgroundA Lipoylated Metabolic Protein Released by Staphylococcus aureus Suppresses Macrophage Activation
Grayczyk, J. P., Harvey, C. J., Laczkovich, I., & Alonzo, F. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.09.004 · Cited by 57
Foster, T. J., & Geoghegan, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00037-8 · Cited by 66
Shumba, P., Shambat, S. M., & Siemens, N. (2019) · Toxins · doi:10.3390/toxins11060332 · Cited by 62
Staphylococcus aureus , Antibiotic Resistance, and the Interaction with Human Neutrophils
Rungelrath, V., & DeLeo, F. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8127 · Cited by 67
“Leukocidin ED (LukED) C-X-C motif chemokine receptor (CXCR1, CXCR2), CCR5 PMN lysis (3, 140)”
Background
Metadata
- Authors
- Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J.
- Affiliations
- New York University (US)
- Corresponding author
- Unutmaz, Derya
- Torres, Victor J.
- ORCID
- Venue
- Nature
- Published
- 2012-12-12
- Volume
- 493
- Issue
- 7430
- Pages
- 51-55
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3536884
- OpenAlex
- W2052831663
- Cited by
- 291
- References
- 43
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 18 · 2023: 17 · 2022: 23 · 2021: 23 · 2020: 26 · 2019: 22 · 2018: 23 · 2017: 19 · 2016: 22 · 2015: 29 · 2014: 23 · 2013: 29
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of Mental Health (R42MH084372, R42-MH084372-02A1)
- National Institute of Allergy and Infectious Diseases (R21AI087973, R01AI065303, T32AI007180, R56AI091856, F32AI098395)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- CCR5, Staphylococcus aureus, pore-forming toxins, immune evasion, CCR5 antagonist, maraviroc, neutrophils, T cells, myeloid cells, HIV co-receptor, bacterial virulence factors
- MeSH terms
- Animals, Bacterial Toxins, Cells, Cultured, Dendritic Cells, Exotoxins, Female, Humans, Immunologic Memory, Staphylococcus aureus, T-Lymphocytes, Cell Death, Jurkat Cells, Receptors, CCR5, Myeloid Cells, Mice, Immune Evasion, CCR5 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.